3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors
A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol...
Saved in:
Published in | Journal of enzyme inhibition and medicinal chemistry Vol. 18; no. 1; pp. 15 - 26 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Informa UK Ltd
01.01.2003
Taylor & Francis |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol, pregnenolone and 20-hydroxy-pregnenolone, no significant inhibition of steroid sulfatase occurred at concentrations of 0.3 and 3 μM. With only a t -butylbenzyl or a benzyl group, a stronger steroid sulfatase inhibition was obtained in the androst-5-ene than in the pregn-5-ene series. Comparative results from the screening tests and the IC 50 values have shown that the effect of a sulfamate moiety as a second inhibiting group can be combined to the t -butylbenzyl or benzyl effect in the C19 and C21 steroid series. The 3 β -sulfamoyloxy-17 α - t -butylbenzyl-5-androsten-17 β -ol (10) was thus found to be the most active compound with IC 50 values of 46 ± 8 and 14 ± 1 nM, respectively for the transformations of E 1 S to E 1 and DHEAS to DHEA. The IC 50 values of compound 10 are similar to that of 17 α - t -butylbenzyl-estradiol, which was previously reported by our group as a good steroid sulfatase reversible inhibitor, but remains higher than that of the potent inactivators estrone-3- O -sulfamate (EMATE) and 17 α - t -butylbenzyl-EMATE. However, contrary to these two latter inhibitors, compound 10 did not induce any proliferative effect on estrogen-sensitive ZR-75-1 cells nor on androgen-sensitive Shionogi cells at concentrations tested, suggesting that this steroid sulfatase inhibitor is non estrogenic and non androgenic. |
---|---|
AbstractList | A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol, pregnenolone and 20-hydroxy-pregnenolone, no significant inhibition of steroid sulfatase occurred at concentrations of 0.3 and 3 μM. With only a t -butylbenzyl or a benzyl group, a stronger steroid sulfatase inhibition was obtained in the androst-5-ene than in the pregn-5-ene series. Comparative results from the screening tests and the IC 50 values have shown that the effect of a sulfamate moiety as a second inhibiting group can be combined to the t -butylbenzyl or benzyl effect in the C19 and C21 steroid series. The 3 β -sulfamoyloxy-17 α - t -butylbenzyl-5-androsten-17 β -ol (10) was thus found to be the most active compound with IC 50 values of 46 ± 8 and 14 ± 1 nM, respectively for the transformations of E 1 S to E 1 and DHEAS to DHEA. The IC 50 values of compound 10 are similar to that of 17 α - t -butylbenzyl-estradiol, which was previously reported by our group as a good steroid sulfatase reversible inhibitor, but remains higher than that of the potent inactivators estrone-3- O -sulfamate (EMATE) and 17 α - t -butylbenzyl-EMATE. However, contrary to these two latter inhibitors, compound 10 did not induce any proliferative effect on estrogen-sensitive ZR-75-1 cells nor on androgen-sensitive Shionogi cells at concentrations tested, suggesting that this steroid sulfatase inhibitor is non estrogenic and non androgenic. |
Author | Ciobanu, Liviu C. Poirier, Donald Luu-The, Van Boivin, Roch P. |
Author_xml | – sequence: 1 givenname: Liviu C. surname: Ciobanu fullname: Ciobanu, Liviu C. organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada – sequence: 2 givenname: Roch P. surname: Boivin fullname: Boivin, Roch P. organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada – sequence: 3 givenname: Van surname: Luu-The fullname: Luu-The, Van organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada – sequence: 4 givenname: Donald surname: Poirier fullname: Poirier, Donald organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada |
BookMark | eNp9kNtOGzEQhq2KSuXQJ-iNX2BbHzZegwQSSTlJCC5Cr1eTzZgYbWw09gZtH4srnoJnYpPQSpUq5uYf_Zr5PP732E6IARn7JsV3Kaz4IctqZLQRWoqhzKGy6hPbXbuF0VW587c35gvbS-lBCCWVLHfZi359LqZd62AJGflPJL-C7FeYeHR8Ig85hDmfKMmnGSn6eeJjBPLhngPPvBh3uW9nGH73LY80eONtf0Gxezzi0z7kBSafNpizFbTdQI-BQ-I3MRSYMsV7DL7ZDKytQf9Y70_yzX0ZEvKrsPAznyOlA_bZQZvw67vus1_nZ3eTy-L69uJqcnpdNFoaVeBaNLqqQqu0mFczNaosggApnMMSrZFQSt1UdkgKnbEKbNnYalQq0Vip95nechuKKRG6-pH8EqivpajX4df_CX_YOtlu-eAiLeEpUjuvM_RtJEcQGp9q_THg-B_AAqHNiwYI64fYURi-_OEBb3O6oTw |
CitedBy_id | crossref_primary_10_1517_13543776_15_11_1541 crossref_primary_10_1016_j_bmc_2020_115368 crossref_primary_10_1016_j_mce_2013_06_022 crossref_primary_10_1080_00304940609355990 crossref_primary_10_1021_cc020115u crossref_primary_10_1016_j_bmcl_2004_07_013 crossref_primary_10_1016_j_bmcl_2016_09_046 crossref_primary_10_1016_j_ejmech_2016_04_044 crossref_primary_10_1016_j_mce_2010_12_035 crossref_primary_10_1016_j_ejmech_2016_02_054 crossref_primary_10_1016_j_jsbmb_2005_02_007 crossref_primary_10_1021_acsmedchemlett_7b00265 crossref_primary_10_1021_cr400230c crossref_primary_10_1016_j_steroids_2012_07_012 crossref_primary_10_1016_j_steroids_2011_03_010 crossref_primary_10_1016_j_jsbmb_2018_05_009 crossref_primary_10_1210_er_2004_0003 crossref_primary_10_1016_j_ejmech_2019_05_023 crossref_primary_10_1016_j_jsbmb_2013_01_013 crossref_primary_10_1002_med_20008 crossref_primary_10_1016_j_steroids_2021_108856 |
ContentType | Journal Article |
Copyright | 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003 |
Copyright_xml | – notice: 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003 |
DBID | AAYXX CITATION |
DOI | 10.1080/1475636031000069282 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1475-6374 |
EndPage | 26 |
ExternalDocumentID | 10_1080_1475636031000069282 11202746 |
Genre | Research Article |
GroupedDBID | --- 00X 0R~ 0YH 29K 36B 4.4 53G 5GY 5VS 7X7 8FI 8FJ A8Z AALIY ABDBF ABPTK ABUWG ACGEJ ACGFS ADBBV ADCVX ADRBQ ADXPE AENEX AEYQI AFKRA AFKVX AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS AOIJS ARJSQ AWYRJ BABNJ BCNDV BENPR BPHCQ BVXVI CAG COF CS3 CZDIS D-I DRXRE DU5 DWTOO EAP EBC EBD EBS EJD EMB EMK EMOBN EPL EST ESX F5P FYUFA GROUPED_DOAJ H13 HYE HZ~ KRBQP KWAYT M44 M4Z O9- OK1 P2P PIMPY PQEST PQQKQ PQUKI PROAC RPM SV3 TFDNU TFL TFW TUS UKHRP V1S ~1N AAYXX ALIPV CCPQU CITATION ESTFP HMCUK NUSFT TDBHL |
ID | FETCH-LOGICAL-c3162-ec3163ef77e8230d7b2578ea0a10ffe4e861a413c78637ef682a84c875420c813 |
IEDL.DBID | 0YH |
ISSN | 1475-6366 |
IngestDate | Fri Aug 23 01:01:30 EDT 2024 Thu Sep 08 17:34:44 EDT 2022 Wed Jun 21 08:14:46 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3162-ec3163ef77e8230d7b2578ea0a10ffe4e861a413c78637ef682a84c875420c813 |
OpenAccessLink | https://www.tandfonline.com/doi/pdf/10.1080/1475636031000069282?needAccess=true |
PageCount | 12 |
ParticipantIDs | informahealthcare_journals_10_1080_1475636031000069282 crossref_primary_10_1080_1475636031000069282 informaworld_taylorfrancis_310_1080_1475636031000069282 |
PublicationCentury | 2000 |
PublicationDate | 1/1/2003 |
PublicationDateYYYYMMDD | 2003-01-01 |
PublicationDate_xml | – month: 01 year: 2003 text: 1/1/2003 day: 01 |
PublicationDecade | 2000 |
PublicationTitle | Journal of enzyme inhibition and medicinal chemistry |
PublicationYear | 2003 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
SSID | ssj0021214 |
Score | 1.7839681 |
Snippet | A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and... |
SourceID | crossref informaworld informahealthcare |
SourceType | Aggregation Database Publisher |
StartPage | 15 |
SubjectTerms | C19 Steroid C21 Steroid Estrogen Inhibitor Sulfamate Sulfatase |
Title | 3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors |
URI | https://www.tandfonline.com/doi/abs/10.1080/1475636031000069282 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBZpcsmlpE1D0z_mUHKqiGV5JTu37DZhW0gu20ByMpI9IoatXdbewvaxcupT9Jk6kr1L2oYcerIRHttoRvpmRsM3jL0vMROhzs8iJjzJYseNGBkupVKWHAihQh-yi0s1vUo-X4-uhz6n7VBW6WNo1xNFhL3aL25j23VF3LFI9MjTXPW5aZVR1PCE7cSasJ8MOrqZbiIuEQdyby_ASUKtaYcefskf0LQ3EJfebsqw_iIzvQdD53vs6eA_wmmv8GdsC-vnbP-0ptj56wqOIFR0hlT5Pvspf93x2XLuDLmlCB_J2L4Hnu8WGgcTkQFNAUxiATOa3aYqWxiT4ROYgYEO-HjZreYW6x-rOTQLGhv39yFfdQKzVU3eY1u14TVnG9pwMC1cNjUnvFk0ZJ9VER7wQ8bTI_RDwych_F9HWAqf6tvKVr77zwt2dX72ZTLlQ6cGXkihYo7-ItFpjf7grtTW7wRoIiMi5zDBVAlDcFnoVEmNTqWxSZMi9e13oyIV8oBt102NLxnEBZYmK3VpXTjTzRCdjaxMEyNcnOEh-7BWUv6tJ-TIxcBz-oBOD5n6R5H5sEzbxwX1fW3nXUiguL7bSS4fkXz135Kv2W6oFQwZnjdsu1ss8S35PJ19F-z6N19K90Q |
link.rule.ids | 315,783,787,27514,27936,27937,59471,59472,61546,61547 |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYoHOgFUWhV6A9zqHqq1TjO2klv7Ba0tLCXBQlOkZ2MRaRtUm2ylZbH4sRT8Ey1nexqC4hDT4lGGSfyjD0_nnxDyKccE-br_DRiRKMkNFSxnqKcC6GtA8GE70N2NhLDi-jHZe9y5S9-V1bpYmjTAkX4vdotbpeMXpTEfWWR7DmcqzY5LRIbNrwgG70kkq6HQXA1XIZcLPTo3o6BWg6xwB16epB_bNN2h1x6vazDeoBmumKHjrfJVudAwmEr8VdkDcsdsntY2uD51xw-gy_p9LnyXXLH72_peDYxyvqlCN-ttv3xQN81VAYGLAE7BzAIGYzt9FZFXkPfar61ZqCgAdqfNfOJxvJmPoFqamn99t4nrL7BeF5a97Euaj_M0RI3HFQNo6qk1uBMK6ugReYfcCTl8BFaUvdK8N_XWGMKJ-V1oQvX_uc1uTg-Oh8MadeqgWaciZCiu3A0UqI7uculdlsBqkCxwBiMMBZMWXuZyVhwiUbEoYqjLHb9d4MsZvwNWS-rEt8SCDPMVZLLXBt_qJsgGh1oHkeKmTDBPfJlIaT0d4vIkbIO6PQJme4R8UiQabdO6-cZ5aq008ZnUEzb7iTlz3Du_zfnAdkcnp-dpqcno5_vyEtfOOjTPe_JejOd4QfrADX6o9fxv8t1-rQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELagSIgLKhREgZY5IE5YxHHWSbh1t11t-VkhLZXKKbKTsRppSapNFml5rJ76FDwTYye7Km3VA6dEVsaxPOP58-gbxt4WmApf52cQIx6loeVaDDSXUilDDoRQvg_Z16manESfTgenfZ_Tpi-rdDG07YAivK52h_u8sOuKuA8iigcO5qrLTauUoob77MEgJT1LAh38mGwiLhF6cG9HwIlCrWGHbp_kH9O03QOXnm3KsK6BmV4xQ-Nt9rj3H-GgY_gTdg-rp2znoKLY-ecK3oGv6PSp8h12Kf9c8NlybjW5pQiHJGy_PM53A7WFkUiBtgBGoYAZ7W5dFg0MSfDJmIGGFvhw2a7mBqvfqznUCxobdu8-X_URZquKvMembPw0RxvYcNANTOuKk71Z1CSfZe4_cEPawSN0Q_0vwa-vJVsKx9VZaUrX_ecZOxkffR9NeN-pgedSqJCje0i0cYzu4q6IjdMEqAMtAmsxwkQJTeYyjxMlY7QqCXUS5YlrvxvkiZDP2VZVV_iCQZhjodMiLoz1d7opojWBkUmkhQ1T3GXv10zKzjtAjkz0OKe38HSXqRuMzPpj2txNGF_ldtb6BIrtup1k8g7Kl_9N-YY9_HY4zr4cTz-_Yo982aBP9rxmW-1iiXvk_rRm34v4Xzn4-d0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=3%CE%B2-Sulfamate+Derivatives+of+C19+and+C21+Steroids+Bearing+a+t+-Butylbenzyl+or+a+Benzyl+Group%3A+Synthesis+and+Evaluation+as+Non-estrogenic+and+Non-androgenic+Steroid+Sulfatase+Inhibitors&rft.jtitle=Journal+of+enzyme+inhibition+and+medicinal+chemistry&rft.au=Ciobanu%2C+Liviu+C.&rft.au=Boivin%2C+Roch+P.&rft.au=Luu-The%2C+Van&rft.au=Poirier%2C+Donald&rft.date=2003-01-01&rft.pub=Taylor+%26+Francis&rft.issn=1475-6366&rft.eissn=1475-6374&rft.volume=18&rft.issue=1&rft.spage=15&rft.epage=26&rft_id=info:doi/10.1080%2F1475636031000069282&rft.externalDocID=11202746 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-6366&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-6366&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-6366&client=summon |